Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - COST OF REVENUE
Cost of Revenue ABUS - Arbutus Biopharma Corporation
73.7 M
LAST VALUE
548.40%
2 YEAR CAGR
4.94%
5 YEAR CAGR
13.13%
10 YEAR CAGR